TCG Opportunity III GP, LLC
CIK 1932445 · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$40.78M
Companies
4
Total Filings
12
Lifetime Open-Market Net
$353.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNYA | 10%+ Owner | 4,253,298 | $0.71 | $3.03M | $38.45M | 3 | 2026-02-12 |
| EIKN | 10%+ Owner | 4,312,139 | $8.75 | $37.73M | $304.96M | 1 | 2026-02-09 |
| SRZNW | 10%+ Owner | 989,893 | $0.02 | $17.9K | $6.27M | 2 | 2026-01-08 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 0 | $1.54 | $0 | $3.45M | 6 | 2024-04-08 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-14 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +600 | $3.0K | EDGAR |
| 2022-11-23 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +80,654 | $403.2K | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.